EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 233 (2026) BIO Web Conf., 233 (2026) 01004 References
Open Access
Issue
BIO Web Conf.
Volume 233, 2026
9th International Conference on Advances in Biosciences and Biotechnology: Emerging Innovations in Biomedical and Bioengineering Sciences (ICABB 2026)
Article Number 01004
Number of page(s) 17
Section Biomedical and Health Innovations
DOI https://doi.org/10.1051/bioconf/202623301004
Published online 23 April 2026
  • T. Wyss-Coray, “Ageing, neurodegeneration and brain rejuvenation,” (in eng), Nature, vol. 539, no. 7628, pp. 180 186, 2016. [Google Scholar]
  • WHO, “Dementia,” 2021. [Google Scholar]
  • R. C. Petersen et al., “Alzheimer’s disease,” Seminars in Neurology, vol. 37, no. 3, pp. 227–237, 2017. [Google Scholar]
  • D. S. Knopman et al., “Alzheimer disease,” Nature Reviews Disease Primers, vol. 7, no. 1, p. 33, 2021. [Google Scholar]
  • W. M. van der Flier and P. Scheltens, “Epidemiology and risk factors of dementia,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 76, suppl. 5, pp. v2-v7, 2005. [Google Scholar]
  • B. N. Dugger and D. W. Dickson, “Pathology of Neurodegenerative Diseases,” Cold Spring Harbor Perspectives in Biology, vol. 9, no. 7, p. a028035, 2017. [Google Scholar]
  • A. V. Terry Jr. and J. J. Buccafusco, “The cholinergic hypothesis of age and Alzheimer’s disease-related cognitive deficits: recent challenges and their implications for novel drug development,” (in eng), Journal of Pharmacology and Experimental Therapeutics, vol. 306, no. 3, pp. 821–827, 2003. [Google Scholar]
  • A. D. Gitler, P. Dhillon, and J. Shorter, “Neurodegenerative disease: models, mechanisms, and a new hope,” (in eng), Disease models & mechanisms, vol. 10, no. 5, pp. 499–502, 2017. [Google Scholar]
  • L. Zhao, J. Li, H. Zhao, and T. Ye, “Mechanisms and interventions of oxidative stress-induced neurodegeneration,” Redox Biology, vol. 64, p. 102778, 2023. [Google Scholar]
  • J. Liu, L. Chang, Y. Song, H. Li, and Y. Wu, “The Role of NMDA Receptors in Alzheimer’s Disease,” (in English), Frontiers in Neuroscience, vol. 13, p. 43, 2019. [Google Scholar]
  • R. Venkatesan, E. Ji, and S. Y. Kim, “Phytochemicals That Regulate Neurodegenerative Disease by Targeting Neurotrophins: A Comprehensive Review,” BioMed Research International, vol. 2015, p. 814068, 2015. [Google Scholar]
  • N. J. Abbott, A. A. K. Patabendige, D. E. M. Dolman, S. R. Yusof, and D. J. Begley, “Structure and function of the blood-brain barrier,” Neurobiology of Disease, vol. 37, no. 1, pp. 13–25, 2010. [Google Scholar]
  • J. Kreuter, “Nanoparticulate systems for brain delivery of drugs,” Advanced Drug Delivery Reviews, vol. 64, pp. 213–222, 2012. [Google Scholar]
  • A. Teleanu, C. Niculescu, R. Teleanu, and D. M. Mitrea, “Blood-brain barrier disruption in neurological disease and therapy,” (in eng), International Journal of Molecular Sciences, vol. 23, no. 7, p. 3782, 2022. [Google Scholar]
  • M. Kolarova, F. Garcia-Sierra, A. Bartos, J. Ricny, and D. Ripova, “Structure and pathology of tau protein in Alzheimer disease,” (in eng), Int J Alzheimers Dis, vol. 2012, p. 731526, 2012. [Google Scholar]
  • G. C. Bhatt, S. Bhattacharya, and T. Mehta, “Prevalence and etiology of dementia: a systematic review and meta analysis,” Neurological Sciences, vol. 44, no. 4, pp. 1227–1239, 2023. [Google Scholar]
  • M. Cummings, J. Zhou, G. Lee, D. Zhong, and T. Fonseca, “Lecanemab: appropriate use recommendations,” Journal of Prevention of Alzheimer's Disease, vol. 10, no. 3, pp. 362–377, 2023. [Google Scholar]
  • M. Esiri et al., “Cerebral amyloid angiopathy, subcortical white matter disease and dementia: literature review and study in OPTIMA,” (in eng), Brain pathology (Zurich, Switzerland), vol. 25, no. 1, pp. 51–62, 2015. [Google Scholar]
  • J. Pradeepkiran and P. H. Reddy, “Defective mitophagy in Alzheimer's disease,” (in eng), Ageing Research Reviews, vol. 64, p. 101191, 2020. [Google Scholar]
  • H. Hampel et al., “The cholinergic system in the pathophysiology and treatment of Alzheimer's disease,” Brain, vol. 141, no. 7, pp. 1917–1933, 2018. [Google Scholar]
  • H. Hampel et al., “Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research,” (in eng), J Prev Alzheimers Dis, vol. 6, no. 1, pp. 2–15, 2019. [Google Scholar]
  • J. Cao, X. Hou, J. Ping, and H. Cai, “Advances in developing novel therapeutic strategies for Alzheimer's disease,” Molecular Neurodegeneration, vol. 13, no. 1, p. 64, 2018. [Google Scholar]
  • H. Hampel et al., “The Amyloid-0 Pathway in Alzheimer's Disease,” Molecular Psychiatry, vol. 26, no. 10, pp. 5481–5503, 2021. [Google Scholar]
  • Z. Cai, “Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review),” (in eng), Mol Med Rep, vol. 9, no. 5, pp. 1533–41, May 2014. [Google Scholar]
  • W. L. Jorgensen, D. S. Maxwell, and J. Tirado-Rives, “Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids,” Journal of the American Chemical Society, vol. 118, no. 45, pp. 11225–11236, 1996. [Google Scholar]
  • D. Shivakumar et al., “Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field,” Journal of Chemical Theory and Computation, vol. 6, no. 5, pp. 15091519, 2010. [Google Scholar]
  • A. G. Atanasov et al., “Natural products in drug discovery: advances and opportunities,” Nature Reviews Drug Discovery, vol. 20, no. 3, pp. 200–216, 2021. [Google Scholar]
  • J. C. Shelley et al., “Epik: a software program for paa prediction and protonation state generation/enumeration,” Journal of Computer-Aided Molecular Design, vol. 21, no. 12, pp. 681–691, 2007. [Google Scholar]
  • R. A. Friesner et al., “Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy,” Journal of Medicinal Chemistry, vol. 47, no. 7, pp. 1739–1749, 2004. [Google Scholar]
  • S. Forli et al., “Computational protein-ligand docking and virtual drug screening with the AutoDock suite,” Nature Protocols, vol. 11, no. 5, pp. 905–919, 2016. [Google Scholar]
  • P. D. Lyne, M. L. Lamb, and J. C. Saxton, “Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring,” Journal of Medicinal Chemistry, vol. 49, no. 16, pp. 4805–4808, 2006. [Google Scholar]
  • R. A. Friesner et al., “Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes,” Journal of Medicinal Chemistry, vol. 49, no. 21, pp. 6177–6196, 2006. [Google Scholar]
  • T. A. Halgren et al., “Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening,” (in eng), J Med Chem, vol. 47, no. 7, pp. 1750–1759, Mar 25 2004. [Google Scholar]
  • R. Abel, L. Wang, E. D. Harder, B. J. Berne, and R. A. Friesner, “Advancing Drug Discovery through Enhanced Free Energy Calculations,” Accounts of Chemical Research, vol. 50, no. 7, pp. 1625–1632, 2017. [Google Scholar]
  • A. Daina, O. Michielin, and V. Zoete, “SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules,” Scientific Reports, vol. 7, no. 1, p. 42717, 2017. [Google Scholar]
  • C. A. Lipinski, “Rule of five in 2015 and beyond: target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions,” Advanced Drug Delivery Reviews, vol. 101, pp. 34–41, 2016. [Google Scholar]
  • P. Banerjee, A. O. Eckert, A. K. Schrey, and R. Preissner, “ProTox-II: a webserver for the prediction of toxicity of chemicals,” (in eng), Nucleic acids research, vol. 46, no. W1, pp. W257–W263, 2018. [Google Scholar]
  • J. Redfern, M. Kinninmonth, D. Burdass, and J. Verran, “Using soxhlet ethanol extraction to produce and test plant material (essential oils) for their antimicrobial properties,” (in eng), Journal of microbiology & biology education, vol. 15, no. 1, pp. 45–46, 2014. [Google Scholar]
  • J. M. Dinore and M. Farooqui, “GC-MS and LC-MS: an integrated approach towards the phytochemical evaluation of methanolic extract of Pigeon Pea [Cajanus cajan (L.) Millsp] leaves,” (in eng), Natural Product Research, vol. 36, no. 8, pp. 2177–2181, 2022. [Google Scholar]
  • M. Trivedi et al., “Liquid Chromatography - Mass Spectrometry (LC-MS) Analysis of Withania somnifera (Ashwagandha) Root Extract Treated with the Energy of Consciousness,” American Journal of Life Sciences, vol. 5, no. 1, pp. 21–30, 2017. [Google Scholar]
  • M. Gupta, S. Thakur, A. Sharma, and S. Gupta, “Qualitative and Quantitative Analysis of Phytochemicals and Pharmacological Value of Some Dye Yielding Medicinal Plants,” Oriental Journal of Chemistry, vol. 29, pp. 475481, 2013. [Google Scholar]
  • M. Mecozzi, M. Pietroletti, and M. Montalto, “Application of FTIR spectroscopy in environmental and materials science,” Spectrochimica Acta Part A, vol. 281, p. 121571, 2022. [Google Scholar]
  • M. Pal, J. Khushbu, S. Bhatt, and R. Vyas, “Rheological characterisation of nanoemulsions: influence of oil type and surfactant composition,” Colloids and Surfaces A, vol. 648, p. 129290, 2022. [Google Scholar]
  • E. Ashari, “Development of a kojic monooleate-enriched oil-in-water nanoemulsion as a potential carrier for hyperpigmentation treatment,” International Journal of Nanomedicine, vol. 2018, pp. 6465–6479, 2018. [Google Scholar]
  • M. S. Jangdey, A. Gupta, and S. Saraf, “Fabrication, in-vitro characterization, and enhanced in-vivo evaluation of carbopol-based nanoemulsion gel of apigenin for UV-induced skin carcinoma,” (in eng), Drug delivery, vol. 24, no. 1, pp. 1026–1036, 2017. [Google Scholar]
  • N. Sharma, S. Mishra, S. Sharma, R. Deshpande, and R. Sharma, “Preparation and Optimization of Nanoemulsions for targeting Drug Delivery,” International Journal of Drug Development and Research, vol. 5, pp. 37–48, 2013. [Google Scholar]
  • M. Trotta, E. Ugazio, and M. R. Gasco, “Pseudo-ternary phase diagrams of lecithin-based microemulsions: influence of monoalkylphosphates,” (in eng), Journal of Pharmacy and Pharmacology, vol. 47, no. 6, pp. 451–454, 1995. [Google Scholar]
  • S. Shafiq et al., “Development and bioavailability assessment of ramipril nanoemulsion formulation,” (in eng), European Journal of Pharmaceutics and Biopharmaceutics, vol. 66, no. 2, pp. 227–243, 2007. [Google Scholar]
  • R. S. Pessoa et al., “Microemulsion of babassu oil as a natural product to improve human immune system function,” (in eng), Drug Design, Development and Therapy, vol. 9, pp. 21–31, 2015. [Google Scholar]
  • J. Xu, J. Tao, and J. Wang, “Design and Application in Delivery System of Intranasal Antidepressants,” (in English), Frontiers in Bioengineering and Biotechnology, Review vol. 8, 2020-December-21 2020. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.